PP
RVMD icon

PDT Partners’s Revolution Medicines RVMD Stock Holding History

PDT Partners’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,778
Closed -$390K – 859
2022
Q3 		$390K Buy
+19,778
New +$435K 0.06% 508
2022
Q2 		– Sell
-12,604
Closed -$322K – 1130
2022
Q1 		$322K Buy
+12,604
New +$274K 0.03% 703
2021
Q1 		– Sell
-11,853
Closed -$469K – 866
2020
Q4 		$469K Buy
+11,853
New +$469K 0.03% 458

Other funds holding RVMD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PDT Partners's RVMD Position: Q4 2022 in Review

PDT Partners sold out of Revolution Medicines (RVMD) in Q4 2022, closing a stake of 19,778 shares — an estimated $390K sold.

PDT Partners first reported a position in RVMD in Q4 2020 and held it in 3 quarters. The position peaked at $469K in Q4 2020. 135 funds tracked by Wall St. Rank hold RVMD as of Q4 2022.

  • PDT Partners reported no remaining Revolution Medicines position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 19,778 Revolution Medicines shares in Q4 2022, an estimated $390K.
  • PDT Partners first reported a position in Revolution Medicines in Q4 2020 and held it in 3 quarters.
  • PDT Partners's Revolution Medicines position peaked at $469K in Q4 2020.
  • 135 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.